Evidence map›Paper›PMID 37182140›Full record

ArticleFrontiers in oncology2023

Optimizing the structure of interdisciplinary tumor boards for effective cancer care.

Friederike Braulke, Kathrin Kober, Andreas Arndt, Maximilian Papendick, Arne Strauss, Christof Maria Kramm, Kai-Martin Thoms, Alexander König, Jochen Gaedcke, Julia Gallwas and 16 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Criteria and indicators to evaluate quality of care in genitourinary tumour boards.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Friederike BraulkeComprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
Kathrin KoberComprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
Andreas ArndtComprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
Maximilian PapendickComprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
Arne StraussDepartment of Urology, University Medical Center Göttingen, Göttingen, Germany.
Christof Maria KrammDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center Göttingen, Göttingen, Germany.
Kai-Martin ThomsDepartment of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Alexander KönigDepartment of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
Jochen GaedckeDepartment of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
Julia GallwasDepartment of Gynaecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.
Svenja WulfDepartment of Gynaecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.
Christoph SzusziesDepartment of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Gerald WulfDepartment of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Ralph RödelDepartment of Otorhinolaryngology, University Medical Center Göttingen, Göttingen, Germany.
Susanne WolferDepartment of Oral and Maxillofacial Surgery, University Medical Center Göttingen, Göttingen, Germany.
Vesna MalinovaDepartment of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany.
Tobias R OverbeckDepartment of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Marc HinterthanerDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Göttingen, Germany.
Joachim LotzInstitute for Diagnostic and Interventional Radiology, University Medical Center Göttingen, Göttingen, Germany.
Friedemann NauckDepartment of Palliative Medicine, University Medical Center Göttingen, Göttingen, Germany.
Marielle ErnstDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen, Göttingen, Germany.
Christine StadelmannInstitute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Philipp StröbelInstitute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
Volker EllenriederDepartment of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
Thomas AsendorfDepartment of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
Stefan RiekenDepartment of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Göttingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multi-professional interdisciplinary tumor boards (ITB) are essential institutions to discuss all newly diagnosed, relapsed or complex cancer patients in a team of specialists to find an optimal cancer care plan for each individual patient with regard to national and international clinical practice guidelines, patient´s preference and comorbidities. In a high-volume cancer center, entity-specific ITBs take place at least once a week discussing a large number of patients. To a high level of expertise and dedication, this also requires an enormous amount of time for physicians, cancer specialists and administrative support colleagues, especially for radiologists, pathologists, medical oncologists and radiation oncologists, who must attend all cancer-specific boards according to certification requirements. Methods: In this 15-month prospective German single-center analysis, we examined the established structures of 12 different cancer-specific ITBs at the certified Oncology Center and demonstrate tools helping to optimize processes before, during and after the boards for optimal, time-saving procedures. Results: By changing pathways, introducing revised registration protocols and new digital supports we could show that the workload of preparation by radiologists and pathologists could be reduced significantly by 22.9% (p=<0.0001) and 52.7% (p=<0.0001), respectively. Furthermore, two questions were added to all registration forms about the patient´s need for specialized palliative care support that should lead to more awareness and early integration of specialized help. Discussion: There are several ways to reduce the workload of all ITB team members while maintaining high quality recommendations and adherence to national and international guidelines.

Indexed as

multi-professional tumor boardspathologyradiologyradio-oncologyspecialized palliative care

Identifiers

PMID37182140
PMCPMC10171921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.